Background The majority of children with cerebral palsy develop spasticity, which interferes
with motor development, function, and participation. This systematic review appraised …

Objective: To evaluate published evidence of efficacy and safety of pharmacologic
treatments for childhood spasticity due to cerebral palsy. Methods: A multidisciplinary panel …

Safer and more effective interventions have been invented for children with cerebral palsy,
but the rapid expansion of the evidence base has made keeping up-to-date difficult …

Importance Cerebral palsy (CP) is the most common childhood physical disability. Early
intervention for children younger than 2 years with or at risk of CP is critical. Now that an …

Botulinum A toxin produces selective and reversible chemodenervation that can be
employed to balance muscle forces across joints in children with cerebral palsy (CP) …

To examine the efficacy of a rehabilitation protocol, focusing on spasticity management
through botulinum toxin A injections in the lower limbs, an etiologically homogeneous group …

OBJECTIVE: To summarize evidence on the rates of co-occurring impairments, diseases,
and functional limitations with cerebral palsy into succinct clinical messages. METHODS: A …

Aim The aim of this study was to describe systematically the best available intervention
evidence for children with cerebral palsy (CP). Method This study was a systematic review of …

BACKGROUND. Spasticity is a prevalent disabling clinical symptom for children with
cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy …

Importance Cerebral palsy describes the most common physical disability in childhood and
occurs in 1 in 500 live births. Historically, the diagnosis has been made between age 12 and …